Top 20 Companies in Global Brain Imaging Modalities Market (2025–2035): Competitive Analysis & Forecast
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a Research Report Published by Spherical Insights & Consulting, The Global Brain Imaging Modalities Market Size is projected to Grow from USD 11.72 Billion in 2024 to USD 21.5 Billion by 2035, at a CAGR of 5.3% during the forecast period 2025–2035. The Global Brain Imaging Modalities Market is driven by the a rapidly aging global population and a parallel surge in the prevalence of severe neurological disorders such as Alzheimer’s, Parkinson’s, and traumatic brain injuries. And technological innovations such as Artificial Intelligence (AI) and machine learning algorithms to enhance the accuracy of neurological diagnosis.
Introduction
The Global Brain Imaging Modalities Market refers to a diverse ecosystem of diagnostic technologies—such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), and Electroencephalography (EEG) designed to non-invasively visualize the structural and functional intricacies of the human brain. this sector is experiencing a robust trajectory of expansion, primarily driven by a rapidly aging global population and a parallel surge in the prevalence of severe neurological disorders like Alzheimer’s, Parkinson’s, and traumatic brain injuries. As clinical demand for early, precise, and preventive diagnostic interventions intensify, healthcare infrastructures worldwide are significantly increasing their investments in sophisticated neuroimaging equipment. Simultaneously, this market growth is being propelled by a wave of groundbreaking technological innovations that are fundamentally redefining diagnostic boundaries. Industry analysts continually highlight the transformative integration of Artificial Intelligence (AI) and machine learning algorithms, which are drastically enhancing image reconstruction, accelerating scan times, and automating anomaly detection to minimize human diagnostic error. Furthermore, the market is undergoing a structural shift toward greater accessibility and patient comfort, spearheaded by the commercialization of portable MRI machines, wearable functional neuroimaging devices, and ultra-high-resolution hybrid systems like PET/MRI scanners. By bridging the gap between urgent clinical necessity and cutting-edge biomedical engineering, these advancements are successfully expanding neurodiagnostic capabilities into point-of-care settings. Ultimately, this market represents a highly dynamic landscape where continuous innovation and rising healthcare demands converge, promising sustained commercial growth and vastly improved patient outcomes.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brain Imaging Modalities Market.
Brain Imaging Modalities Market Size & Statistics
- The Market Size for Brain Imaging Modalities Was Estimated to be worth USD 11.72 Billion in 2024.
- The Market is Going to Expand at a CAGR of 5.3% between 2025 and 2035.
- The Global Brain Imaging Modalities Market Size is anticipated to reach USD 21.5 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Brain Imaging Modalities Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Brain Imaging Modalities Market.

Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Brain Imaging Modalities market. Asia Pacific is expected to grow fastest due to aggressive economic investments aimed at modernizing healthcare systems and a massive, aging patient demographic in emerging economies such as China and India. Additionally, rising public awareness regarding the critical importance of early neurological diagnosis and an increasing demand for accessible medical imaging are driving unprecedented market expansion across the region.
North America is expected to generate the highest demand during the forecast period in the Brain Imaging Modalities market. North America is expected to generate the highest demand due to the region's highly advanced healthcare infrastructure, substantial ongoing investments in neurological research, and the strong presence of leading medical device manufacturers. Furthermore, the early adoption of AI-enhanced diagnostic tools, coupled with a high prevalence of neurological disorders and supportive reimbursement policies in the US and Canada, continuously cement its market leadership.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brain Imaging Modalities Market.
Top 10 Trends in the Brain Imaging Modalities Market
- Integration of Artificial Intelligence and Machine Learning
- Portable & Wearable Brain Scanners
- Development of Ultra-High-Field MRI Systems
- Hybrid and Multimodal Imaging Systems
- Advancements in high Density & Wireless EEG
- Functional Near-Infrared Spectroscopy & Cloud Analytics
- Automated 3D Quantification & Image Processing Software
- Ethical Data Privacy & Cybersecurity in Neuroimaging
- Sustainable MRI Designs
- Shift Towards Outpatient and Point-of-Care Imaging Facilities
- Integration of Artificial Intelligence (AI) and Machine Learning (ML)
Artificial Intelligence and Machine Learning are fundamentally revolutionizing the brain imaging modalities market by drastically enhancing diagnostic accuracy and operational efficiency. AI algorithms are now seamlessly integrated into MRI and PET systems to automate complex image segmentation, detect subtle abnormalities like early-stage amyloid deposits in Alzheimer’s, and predict disease progression with unprecedented precision.
- Rise of Portable and Wearable Brain Scanners
The miniaturization of neuroimaging technology has sparked a massive shift toward portable and wearable brain scanning devices, effectively democratizing access to critical diagnostics. Historically confined to large, specialized hospital radiology departments, imaging modalities like MRI and EEG are now being redesigned for point-of-care settings, including intensive care units, ambulances, and remote rural clinics.
- Hybrid and Multimodal Imaging Systems
The clinical demand for comprehensive neurological assessments has driven the rapid adoption of hybrid and multimodal imaging systems, most notably the integration of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI). By fusing these two powerful modalities into a single, simultaneous scan, clinicians can seamlessly map both the precise structural anatomy and the underlying metabolic function of the brain in real time. This combined approach eliminates the need for sequential scanning, thereby reducing patient anxiety, lowering radiation exposure, and cutting down overall healthcare costs.
- Functional Near-Infrared Spectroscopy (fNIRS) and Cloud Analytics
Functional Near-Infrared Spectroscopy (fNIRS) is rapidly gaining traction as a highly adaptable and cost-effective alternative to traditional functional MRI for assessing cortical hemodynamics. Its non-invasive nature, relative tolerance to patient motion, and lower operational costs have expanded its application beyond strict laboratory confines into rehabilitation centers, pediatric clinics, and behavioral research settings. Recent trends show a strong convergence of miniaturized fNIRS hardware with cloud-native analytics, enabling seamless, large-scale data processing and remote collaborative research.
- Automated 3D Quantification and Image Processing Software
The sheer volume and complexity of data generated by modern brain scanners have necessitated the rapid development of advanced image processing and automated 3D quantification software. Independent software platforms are now a major market segment, operating alongside the physical scanning hardware to extract maximum clinical value from raw diagnostic data. These sophisticated tools can automatically calculate the exact volumes of specific brain structures, map complex vascular networks, and highlight microstructural abnormalities in stunning three-dimensional clarity. By converting subjective visual assessments into objective, quantifiable metrics, this software significantly enhances the reproducibility and accuracy of neurological diagnoses.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Brain Imaging Modalities market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brain Imaging Modalities Market.
Top 20 Companies Leading the Brain Imaging Modalities Market
- Siemens Healthineers
- GE Healthcare
- Canon Medical Systems Corporation
- Koninklijke Philips
- Hitachi
- Fujifilm Holdings Corporation
- Medtronic
- Aspect Imaging
- Qantib
- Brainomix Ltd
- Imaging Biometrics
- Shanghai United Imaging Healthcare
- Advanced Brain Monitoring
- Postrigo AG
- Mediso
- BrainLab AG
- Shimadzu Corporation
- Neurologica Corporation
- MR Solutions
- Vuno Co Ltd
- Siemens Healthineers
Headquarters: Erlangen, Germany
Siemens Healthineers, active in over 180 countries, is a highly specialized brain imaging modalities market, Siemens Healthineers is universally recognized as a dominant, tier-one manufacturer. The company is actively driving the neuroimaging sector forward through its relentless development of state-of-the-art Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) systems. They are particularly renowned for their ultra-high-field 7-Tesla MRI scanners, which offer unprecedented resolution of the human brain's micro-architecture, enabling researchers to visualize subtle neurological anomalies that were previously undetectable.
- GE Healthcare
Headquarters: Chicago, Illinois, USA
GE Healthcare, active in over 160 countries, a foundational pillar, supplying an extensive portfolio of cutting-edge hardware and specialized contrast agents. GE HealthCare is a leading manufacturer of high-resolution MRI and Computed Tomography (CT) systems that are heavily utilized in neuro-critical care and routine neurological assessments. Beyond scanning hardware, they are uniquely active in the development of molecular imaging technologies, specifically advanced radiopharmaceuticals and PET tracers. These tracers are absolutely vital for the early, preclinical visualization of toxic protein accumulations in the brain, which are the primary biomarkers for Alzheimer’s disease.
- Koninklijke Philips
Headquarters: Amsterdam, Netherlands, USA
Koninklijke Philips, active in over 100 countries, a highly influential innovator, particularly celebrated for its commitments to both diagnostic excellence and environmental sustainability. One of their most disruptive activities in the neuroimaging space is the commercialization of their proprietary BlueSeal magnet technology for MRI scanners. This groundbreaking, fully sealed system operates with a micro-fraction of the liquid helium required by traditional scanners, completely eliminating the risk of helium boil-off and making high-field brain imaging far more sustainable.
- Canon Medical Systems Corporation.
Headquarters: Otawara, Tochigi, Japan
Canon Medical System Corporation, active in 150 countries, globally respected medical equipment manufacturer with a rich history of prioritizing patient safety, diagnostic confidence, and advanced biomedical engineering, particularly renowned for pushing the absolute limits of image resolution and noise reduction. The company is highly active in the manufacturing of ultra-premium MRI and CT scanners utilized heavily in complex neuro-vascular and neuro-oncological assessments. Their most defining contribution to the current neuroimaging landscape is the development and integration of their Advanced Intelligent Clear-IQ Engine (AiCE). This deep learning reconstruction technology utilizes advanced artificial intelligence to rapidly decipher complex neural data, aggressively removing noise from brain images while preserving intricate anatomical details.
- Medtronic
Headquarters: Dublin, Ireland
Medtronic, active in over 150 countries, is a its activity within the specialized brain imaging modalities market is absolutely critical, specifically in the domain of intraoperative neuroimaging. Medtronic is the dominant force in developing image-guided surgery platforms. They actively manufacture the O-arm surgical imaging system, which provides real-time, 3D imaging of the patient's anatomy while they are on the operating table. When this real-time imaging is seamlessly integrated with their StealthStation neuro-navigation software, neurosurgeons can visualize the exact location of their surgical instruments.
Are you ready to discover more about the Brain Imaging Modalities market?
The report provides an in-depth analysis of the leading companies operating in the global brain imaging modalities market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brain Imaging Modalities Market.
Company Profiles
- Siemens Healthineers
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- GE Healthcare
- Canon Medical Systems Corporation
- Koninklijke Philips
- Hitachi
- Fujifilm Holdings Corporation
- Medtronic
- Aspect Imaging
- Qantib
- Others.
Conclusion
The global brain imaging modalities market is witnessing robust and accelerated growth, primarily driven by a rising clinical demand for precise neurological diagnostics, continuous technological advancements, and a rapidly expanding global aging demographic. Advanced brain imaging modalities provide highly accurate, non-invasive, and comprehensive diagnostic solutions for hospital, research, and emerging point-of-care applications. These technologies empower clinicians by enabling the early, preclinical detection of severe neurodegenerative disorders, ultimately improving personalized treatment pathways and long-term patient outcomes. Furthermore, groundbreaking innovations in artificial intelligence integration, ultra-high-field MRI resolution, multimodal hybrid systems, and accessible portable scanners continue to significantly enhance diagnostic performance, workflow efficiency, and clinical reliability. Leading medical technology companies, such as Siemens Healthineers, GE HealthCare, Koninklijke Philips N.V, Canon Medical Systems, and Medtronic, are aggressively expanding their global footprint, contributing immensely to market development. Overall, advanced brain imaging modalities play a vital, irreplaceable role in advancing neurodiagnostic and elevating global healthcare standards.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?